IO Biotech, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-10.0M | $-10.0M | — | $64.0K |
| FY2021 | $-40.6M | $-40.8M | $153.0K | $1.8M |
| FY2022 | $-59.7M | $-60.4M | $690.0K | $7.0M |
| FY2023 | $-71.7M | $-72.1M | $323.0K | $8.1M |
| FY2024 | $-82.3M | $-82.4M | $44.0K | $6.5M |